Wang JP et al. |
Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa). |
1985 |
Am. J. Chin. Med. |
pmid:3927704
|
Yan LG et al. |
Injectable caltrop fruit saponin protects against ischemia-reperfusion injury in rat brain. |
2011 |
Am. J. Chin. Med. |
pmid:21476209
|
Takase B et al. |
Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction. |
1994 |
Am. J. Cardiol. |
pmid:8198031
|
Fulton DR et al. |
Effects of current therapy of Kawasaki disease on eicosanoid metabolism. |
1988 |
Am. J. Cardiol. |
pmid:2454025
|
Catella-Lawson F et al. |
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. |
2001 |
Am. J. Cardiol. |
pmid:11472700
|
Hanet C et al. |
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. |
1987 |
Am. J. Cardiol. |
pmid:2953226
|
Faraday N et al. |
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. |
2006 |
Am. J. Cardiol. |
pmid:16950183
|
Yasu T et al. |
Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. |
1993 |
Am. J. Cardiol. |
pmid:8480641
|
Willerson JT et al. |
Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes. |
1990 |
Am. J. Cardiol. |
pmid:2146868
|
McDaniel HG et al. |
Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction. |
1983 |
Am. J. Cardiol. |
pmid:6416046
|
De Caterina R et al. |
Inhibition of platelet function by injectable isosorbide dinitrate. |
1984 |
Am. J. Cardiol. |
pmid:6428211
|
Eldar M et al. |
Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery. |
1992 |
Am. J. Cardiol. |
pmid:1466338
|
Dabaghi SF et al. |
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. |
1994 |
Am. J. Cardiol. |
pmid:7942533
|
Graziani F et al. |
Thromboxane production in morbidly obese subjects. |
2011 |
Am. J. Cardiol. |
pmid:21439532
|
Théroux P et al. |
Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris. |
1990 |
Am. J. Cardiol. |
pmid:2109927
|
Feldman M and Cryer B |
Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. |
1999 |
Am. J. Cardiol. |
pmid:10468077
|
Willerson JT et al. |
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. |
1984 |
Am. J. Cardiol. |
pmid:6391133
|
Hirsh PD et al. |
Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. |
1983 |
Am. J. Cardiol. |
pmid:6829431
|
Walinsky P et al. |
Beneficial effects of ibuprofen in pacing-induced myocardial ischemia. |
1983 |
Am. J. Cardiol. |
pmid:6829434
|
Milani M et al. |
Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. |
1995 |
Am. J. Cardiol. |
pmid:7604798
|
Roy L et al. |
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol. |
1983 |
Am. J. Cardiol. |
pmid:6823861
|
Shen H et al. |
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). |
2009 |
Am. J. Cardiol. |
pmid:19660620
|
Lam JY et al. |
Platelet aggregation, coronary artery disease progression and future coronary events. |
1994 |
Am. J. Cardiol. |
pmid:8109546
|
Timmermans C et al. |
Ridogrel in the setting of percutaneous transluminal coronary angioplasty. |
1991 |
Am. J. Cardiol. |
pmid:1872272
|
Mason PJ et al. |
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. |
2005 |
Am. J. Cardiol. |
pmid:16275179
|
Rehr RB et al. |
Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations. |
1984 |
Am. J. Cardiol. |
pmid:6437206
|
Montalescot G et al. |
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries. |
1990 |
Am. Heart J. |
pmid:2248190
|
Hirsh PD et al. |
Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease. |
1982 |
Am. Heart J. |
pmid:7102506
|
Smith EF and Lefer AM |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. |
1981 |
Am. Heart J. |
pmid:7211667
|
Nakashima Y et al. |
Sustained-release nifedipine (nifedipine-L) suppresses plasma thromboxane B2 and 6-keto prostaglandin F1 alpha in both young male smokers and nonsmokers. |
1990 |
Am. Heart J. |
pmid:2353613
|
Ikonomidis I et al. |
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. |
2005 |
Am. Heart J. |
pmid:15894964
|
Kishi Y et al. |
Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris. |
1992 |
Am. Heart J. |
pmid:1736562
|
Tomoda H |
Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). |
1986 |
Am. Heart J. |
pmid:3532743
|
Nitz RE and Martorana PA |
The activity of molsidomine in experimental models of ischemic cardiac disease. |
1985 |
Am. Heart J. |
pmid:3919549
|
Buchanan MR et al. |
Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease. |
1987 |
Am. Heart J. |
pmid:2953219
|
Walinsky P et al. |
Thromboxane A2 in acute myocardial infarction. |
1984 |
Am. Heart J. |
pmid:6485997
|
Rubenstein MD et al. |
Platelet activation in clinical coronary artery disease and spasm. |
1981 |
Am. Heart J. |
pmid:6455912
|
De Caterina R et al. |
Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects. |
1990 |
Am. Heart J. |
pmid:2321506
|
Lorenzoni R et al. |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. |
2004 |
Am. Heart J. |
pmid:15215815
|
Buerke M et al. |
Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. |
1995 |
Am. Heart J. |
pmid:7661062
|
Mehta J et al. |
Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina. |
1984 |
Am. Heart J. |
pmid:6695662
|
De Servi S et al. |
Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations. |
1987 |
Am. Heart J. |
pmid:3630891
|
Cotter G et al. |
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? |
2004 |
Am. Heart J. |
pmid:14760328
|
Mehta J and Mehta P |
Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. |
1985 |
Am. Heart J. |
pmid:3880988
|
Friedrich T et al. |
Follow-up of prostaglandin plasma levels after acute myocardial infarction. |
1985 |
Am. Heart J. |
pmid:3880994
|
O'Connor KM et al. |
The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models. |
1989 |
Am. Heart J. |
pmid:2929400
|
Zhu BQ and Parmley WW |
Modification of experimental and clinical atherosclerosis by dietary fish oil. |
1990 |
Am. Heart J. |
pmid:2105047
|
Neri Serneri GG et al. |
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. |
1985 |
Am. Heart J. |
pmid:3984828
|
O'Connor KM et al. |
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion. |
1986 |
Am. Heart J. |
pmid:3953390
|
Roy L et al. |
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease. |
1985 |
Am. Heart J. |
pmid:3158183
|
Austin JC et al. |
Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion. |
1988 |
Am. Heart J. |
pmid:3344655
|
Yamada Y et al. |
Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator. |
1991 |
Am. Heart J. |
pmid:1903579
|
Arora RR et al. |
Laser-induced stimulation of thromboxane B2 synthesis in human blood platelets: role of superoxide radicals. |
1993 |
Am. Heart J. |
pmid:8381256
|
FitzGerald GA et al. |
Cigarette smoking and hemostatic function. |
1988 |
Am. Heart J. |
pmid:3276116
|
Jouve R et al. |
Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. |
1984 |
Am. Heart J. |
pmid:6581715
|
Rebuzzi AG et al. |
Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. |
1992 |
Am. Heart J. |
pmid:1539506
|
Cambria RA et al. |
Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. |
1991 |
Am Surg |
pmid:1847027
|
Ingster LM and Feinleib M |
Salicylate intake and cardiovascular disease: Ingster and Feinleib respond to Hu and Willett. |
1998 |
Am J Public Health |
pmid:9702172
|
Satterfield S et al. |
Biochemical markers of compliance in the Physicians' Health Study. |
1990 Sep-Oct |
Am J Prev Med |
pmid:2268456
|
Natarajan G et al. |
Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants. |
2008 |
Am J Perinatol |
pmid:18726836
|
Brown HL et al. |
Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. |
1987 |
Am J Perinatol |
pmid:3566883
|
Mehta P et al. |
Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. |
1985 |
Am J Pediatr Hematol Oncol |
pmid:2994511
|
Jung TT and Juhn SK |
Prostaglandins in human cholesteatoma and granulation tissue. |
1988 |
Am J Otol |
pmid:3177602
|
Leese PT et al. |
Valdecoxib does not impair platelet function. |
2002 |
Am J Emerg Med |
pmid:12098171
|
Andersson T et al. |
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers. |
2012 |
Am J Cardiovasc Drugs |
pmid:22631032
|
Elissalde MH and Beier RC |
Stimulation and release of prostaglandins and thromboxane from macrophages by cotton dust associated lipopolysaccharides. |
1990 |
Am Ind Hyg Assoc J |
pmid:2270833
|
Tanaka H et al. |
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. |
1999 |
Allergy |
pmid:10380781
|
Oosaki R et al. |
Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. |
1997 |
Allergy |
pmid:9188934
|
Mita H et al. |
Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. |
2001 |
Allergy |
pmid:11703219
|
Collins CE et al. |
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791957
|
Treiber G et al. |
The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16393293
|
Van Hecken A et al. |
Effects of enteric-coated, low-dose aspirin on parameters of platelet function. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12197849
|
Cole AT et al. |
Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7865644
|
Carty E et al. |
Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848666
|
Wannhoff A et al. |
Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26919285
|
Signore C et al. |
Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. |
2008 |
Alcohol. Clin. Exp. Res. |
pmid:18715278
|
Siler-Khodr TM et al. |
Effect of ethanol on thromboxane and prostacyclin production in the human placenta. |
2000 |
Alcohol |
pmid:10963940
|
Hillbom M et al. |
Effects of ethanol on platelet function. |
1985 May-Jun |
Alcohol |
pmid:4026960
|
Shalina RI et al. |
[Synthesis of prostaglandins and lipid peroxidation in pregnant women with gestosis]. |
1988 |
Akush Ginekol (Mosk) |
pmid:3213902
|
Bashakin NF et al. |
[The functional characteristics of the prostacyclin-thromboxane system in newborn infants with a history of acute and chronic intrauterine hypoxia]. |
1993 |
Akush Ginekol (Mosk) |
pmid:8311150
|
Fernández-Cruz E et al. |
Increased synthesis and production of prostaglandin E2 by monocytes from drug addicts with AIDS. |
1989 |
AIDS |
pmid:2496725
|
Patrono C et al. |
Radioimmunoassay measurement of stable metabolites of platelet arachidonic acid: a convenient method for the in vitro and ex vivo evaluation of cyclo-oxygenase inhibitors. |
1980 |
Agents Actions Suppl. |
pmid:6787852
|
Patrono C et al. |
Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment. |
1979 |
Agents Actions Suppl. |
pmid:115255
|
Chignard M et al. |
Arachidonate-mediated bronchoconstriction and platelet activation are inhibited by microgram doses of compound L8027 which are not selective for thromboxane synthetase. |
1979 |
Agents Actions Suppl. |
pmid:291306
|
Peskar BA and Holland A |
Plasma levels of immunoreactive 15-keto-13,14-dihydro-thromboxane B2 in guinea pigs during anaphylaxis and after histamine injection. |
1979 |
Agents Actions Suppl. |
pmid:294148
|
Cerletti C et al. |
Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man. |
1986 |
Agents Actions Suppl. |
pmid:3101444
|
Mihai K et al. |
Association between total cholesterol and thromboxane B2 levels in offspring of parents suffering from premature coronary artery disease. |
1992 |
Agents Actions Suppl. |
pmid:1632293
|
Petö J et al. |
Association between total cholesterol and plasma thromboxane B2 in human adults. |
1992 |
Agents Actions Suppl. |
pmid:1632296
|
Mentz P and Giessler C |
Biosynthesis of TXB2 and 6-oxo-PGF1 alpha in the heart and other tissues under pathophysiological conditions. |
1992 |
Agents Actions Suppl. |
pmid:1632315
|
De Clerck F et al. |
Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. |
1983 |
Agents Actions |
pmid:6858790
|
Nosál R et al. |
Antihistaminic drug bromadryl and stimulated platelet aggregation. |
1994 |
Agents Actions |
pmid:7976789
|
Conti P et al. |
Augmentation of thromboxane production in vitro by polymorphonuclears and macrophages exposed to IL1/LP. |
1986 |
Agents Actions |
pmid:3485895
|
Zatta A et al. |
At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. |
1987 |
Agents Actions |
pmid:2961218
|
de Clerck F et al. |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. |
1982 |
Agents Actions |
pmid:6215842
|
de Clerck F et al. |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982. |
1994 |
Agents Actions |
pmid:7725978
|
Ghanem NS and Assem ES |
Comparison of the release of various mediators from atrial and ventricular tissues of sensitized guinea-pig hearts. |
1987 |
Agents Actions |
pmid:2440280
|
Atzori L et al. |
Vasoconstriction and bronchoconstriction induced by 2,5-di-(tert-butyl)1,4-benzohydroquinone, an endoplasmic reticular Ca2+-ATPase inhibitor, in isolated and perfused rat lung. |
1992 |
Agents Actions |
pmid:1414686
|
Abdullah NA and Assem ES |
Ischaemia and mediator release: interrelationship in antigen-challenged sensitized guinea-pig kidney. |
1990 |
Agents Actions |
pmid:1695424
|
Hoult JR et al. |
Failure of anti-inflammatory steroids to inhibit prostaglandin release from the hydronephrotic rabbit kidney. |
1986 |
Agents Actions |
pmid:3962772
|
Lesch ME et al. |
The effects of (R)-N-(1-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist on rat acute models of inflammation and neutrophil function. |
1991 |
Agents Actions |
pmid:1838897
|